EYLEA | AFLIBERCEPT | ROQUE Eye Clinic | Eye.com.ph

    Eylea | Aflibercept


    EYLEA enables proactive therapy approved for multiple retinal diseases.

    EYLEA is the only anti-angiogenic therapy that inhibits vascular endothelial growth factor A (VEGF-A) and Placental Growth Factor (PlGF).

    EYLEA's license may allow for a proactive, treat-and-extend dosing approach that is approved for the treatment of:

    • wet age-related macular degeneration (wet AMD),
    • diabetic macular edema (DME), and
    • central retinal vein occlusion (CRVO).

    Dr. Manolette Roque
    Dr. Manolette Roque
    Dr. Manolette Roque is an ophthalmologist whose practice includes general ophthalmology (which includes cataract surgery) with subspecialty work in uveitis and ocular immunology, cornea and external disease, and refractive surgery.
    Click to access the login or register cheese
    x Logo: ShieldPRO
    This Site Is Protected By